DACH unquote
Digital+ Partners gears up for fundraise
GP focuses on later-stage B2B technology companies and closed its previous fund in 2018 on €350m
Q1 DACH VC and growth deals surpass previous volume high
Deal volume has grown steadily since Q2 2019; aggregate value has also been rising since Q2 2020
Chequers Capital to carve out Corning Services
GP plans to assist the telecommunications service with a buy-and-build strategy
Hg-backed MeinAuto postpones IPO
Car sales platform cited "currently adverse conditions for high-growth companies" in a statement
HIG acquires majority stake in Infratech Bau
GP intends to support the infrastructure project contractor through organic and acquisitive growth
Paragon’s Apontis Pharma completes IPO
GP acquired the single-pill producer in a carve-out in 2018 and will retain a 31% stake
Equistone buys majority stake in TimeToAct
Germany-based IT consultancy is to be Equistone's fourth platform investment of 2021
YielCo holds closes for PE and co-investment funds
YielCo Special Situations Europe II is targeting €300m; YielCo Defensive Investments targets €150m
Andera Partners lines up DACH expansion plans
Starting with BioDiscovery 6, the GP intends to accelerate fundraising and deal-making in the region
CVC leads growth investment in Acronis
Cybersecurity software developer is valued at $2.5bn, compared with $1bn at its last funding round in 2019
Gimv increases stake in GPNZ
Gimv has increased the size of the majority stake that it already held in the dental chain
Golding makes hires for new impact investing team
Fund-of-funds manager is to launch its first impact fund in H2 2021, having hired the team of Sonanz
Hg's MeinAuto sets IPO price range
Shares are each priced in the €16-20 range, corresponding to a €1.2-1.5bn market capitalisation
Gyrus holds close for Gyrus Investment Program
Program comprises Gyrus Principal Fund and its co-investment Cortex fund; it has a €400m hard-cap
Hannover Finanz, Arcus acquire Löwenstark
Mittelstand-focused GPs aim to support the online marketing firm's growth and succession planning
Paragon-backed Apontis Pharma sets IPO price range
Shares are priced at €18.5-24.5, with a final pricing expected on 6 May before the 11 May listing
VCs in $75m round for Kaia Health
Digital physical therapy platform is backed by all existing investors, including Balderton Capital
Corten buys Emeram's Matrix42
SBO of the digital workspace software is Corten's first investment from its €392m debut fund
Gilde Healthcare buys Acti-Med
Deal is the fourth platform investment from the GP's €200m Gilde Healthcare Services III fund
Capiton, Nord Holding sell Engelmann Sensor to DPE
Smart meter business is the final portfolio company in Capiton's 2010-vintage fourth fund
Telemos Capital acquires Mammut
Conzzeta began to explore sale options for the Swiss outdoor clothing and hardware brand in 2019
Maguar Capital invests in Bregal-backed STP
Maguar partner Gunther Thies founded STP; partner Arno Poschik was on STP's board during his time at Hg
Appetite for DACH tech deals continues apace in Q1
Sponsor demand for differentiated IT services and roll-up strategies remains consistent
KKR sells minority stake in Hensoldt
Leonardo is to buy the 25.1% stake for €606m; KKR will retain an 18% stake in the sensor developer